Media headlines about Acadia Healthcare (NASDAQ:ACHC) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Acadia Healthcare earned a news sentiment score of 0.01 on Accern’s scale. Accern also gave news headlines about the company an impact score of 43.2843420211684 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- The New Notary 4 Rotary Application Defines The New Notary (econotimes.com)
- ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES … (globenewswire.com)
- ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. – ACHC (finance.yahoo.com)
- Investors Buy High Volume of Put Options on Acadia Healthcare (ACHC) (americanbankingnews.com)
- Acadia Healthcare (ACHC) Expected to Announce Quarterly Sales of $730.01 Million (americanbankingnews.com)
Shares of NASDAQ ACHC opened at $39.18 on Monday. Acadia Healthcare has a 1-year low of $26.92 and a 1-year high of $54.34. The company has a current ratio of 1.25, a quick ratio of 1.25 and a debt-to-equity ratio of 1.25. The firm has a market capitalization of $3,458.54, a price-to-earnings ratio of 17.03, a P/E/G ratio of 1.28 and a beta of 0.69.
A number of analysts have recently issued reports on ACHC shares. Credit Suisse Group restated a “neutral” rating and issued a $40.00 price target (up previously from $35.00) on shares of Acadia Healthcare in a report on Thursday, February 22nd. Wells Fargo assumed coverage on Acadia Healthcare in a report on Tuesday, January 30th. They issued an “outperform” rating and a $41.00 price target for the company. Royal Bank of Canada restated a “buy” rating and issued a $45.00 price target on shares of Acadia Healthcare in a report on Tuesday, February 27th. BidaskClub cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Wednesday, January 10th. Finally, Cantor Fitzgerald upgraded Acadia Healthcare from a “neutral” rating to an “overweight” rating in a report on Sunday, February 25th. Six analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and an average price target of $44.50.
In related news, Director Reeve B. Waud sold 150,000 shares of the stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $38.67, for a total value of $5,800,500.00. Following the completion of the transaction, the director now owns 10,088 shares in the company, valued at approximately $390,102.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Randall P. Goldberg sold 960 shares of the stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $38.47, for a total value of $36,931.20. Following the completion of the transaction, the vice president now owns 6,942 shares of the company’s stock, valued at approximately $267,058.74. The disclosure for this sale can be found here. Insiders have sold 401,360 shares of company stock valued at $15,759,096 in the last ninety days. Company insiders own 11.10% of the company’s stock.
WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Acadia Healthcare (ACHC) Share Price” was originally posted by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.wkrb13.com/2018/04/02/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-acadia-healthcare-achc-share-price.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.